Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Mixed Tumor, Malignant × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 291 Skin Neoplasms 153 Carcinoma, Basal Cell 83 Breast Neoplasms 55 Keratosis, Actinic 53 Lymphoma, T-Cell, Cutaneous 52 Leukemia, Lymphocytic, Chronic, B-Cell 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Mycosis Fungoides 41 Lymphoma, Non-Hodgkin 41 Sezary Syndrome 39 Lymphoma, Large B-Cell, Diffuse 39 Lymphoma, Follicular 39 Carcinoma, Squamous Cell 39 Lymphoma, Mantle-Cell 38 Lymphoma, B-Cell, Marginal Zone 38 Burkitt Lymphoma 38 Lymphoma, Large-Cell, Immunoblastic 36 Hodgkin Disease 36 Multiple Myeloma 35 Lymphoma 34 Neoplasms 33 Leukemia, Myeloid, Acute 31 Myeloproliferative Disorders 30 Leukemia, Myeloid, Accelerated Phase 30 Leukemia, Myeloid, Chronic-Phase 29 Primary Myelofibrosis 27 Lung Neoplasms 27 Leukemia, Hairy Cell 27 Congenital Abnormalities 27

Interventions

Tomography, Optical Coherence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02851693 2019-04-04

OCTSKIN

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Withdrawn

Carcinoma, Keratosis, Mixed Tumor, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡